Diagnostics Pipeline: FDA Approves Visby Medical’s Over-The-Counter Women’s Sexual Health Test
It’s the first PCR-based sexually transmitted infection test platform for at-home use
It’s the first PCR-based sexually transmitted infection test platform for at-home use
Understanding the regulatory landscape of genetic and genomic testing, and its impact on clinical practice
How three companies are addressing screening challenges with tests that help improve chances of early detection
Many artificial intelligence-based medical devices have not undergone clinical validation—but what does this mean for the lab?
Expansion of use for two assays gives patients the option to self-collect specimens at home and in the clinic, which may help address gaps in screening
Experts—including those in genetics and device regulation—say the AvertD assay did not predict risks of abuse ‘any better than chance’
NIH grant awarded to Metabolon is the first phase of what could be a three-year grant, according to a company official
The grants, which include $3 million from the NIH and $1 million from the NSF, will help the company develop point-of-care tests
Publishing peer-reviewed studies to tout the economic benefits of medical devices is fairly commonplace, but rare for a laboratory company
Though not expected to drastically change the program, new component gives device makers another way to strengthen their submissions
The FDA is adding International Organization for Standardization (ISO) guidelines to its “good manufacturing” requirements